Liver DiseasesLiverLiver TransplantationLiver NeoplasmsLiver CirrhosisMicrosomes, LiverLiver RegenerationFatty LiverKidney TransplantationLiver Function TestsMitochondria, LiverDrug-Induced Liver InjuryTransplantsGraft RejectionGraft SurvivalLiver CirculationLiver ExtractsImmunosuppressive AgentsLiver Neoplasms, ExperimentalLiver Failure, AcuteTissue DonorsLiver AbscessTransplantation, HomologousLiver Diseases, AlcoholicHeart TransplantationTransplantationHepatectomyTime FactorsLiving DonorsHepatocytesEnd Stage Liver DiseaseLung TransplantationTissue and Organ ProcurementLiver Cirrhosis, AlcoholicTreatment OutcomeLiver Cirrhosis, ExperimentalRetrospective StudiesLiver, ArtificialCarcinoma, HepatocellularPostoperative ComplicationsTacrolimusLiver GlycogenAlanine TransaminaseWaiting ListsBone Marrow TransplantationCyclosporineRats, Inbred StrainsImmunosuppressionKidneyHematopoietic Stem Cell TransplantationHepatitisRNA, MessengerFetal Tissue TransplantationCadaverCytomegalovirus InfectionsPortal VeinMycophenolic AcidCarbon TetrachlorideRisk FactorsKineticsFollow-Up StudiesHistocompatibility TestingRats, WistarKupffer CellsCytochrome P-450 Enzyme SystemHepatic ArteryTransplantation ImmunologyRats, Sprague-DawleyImmunocompromised HostBilirubinKidney Failure, ChronicTissue DistributionBile DuctsDisease Models, AnimalRats, Inbred F344Survival RateOrgan SizeRecurrenceGraft vs Host DiseaseCholestasisPerfusionSurvival AnalysisLiver FailureMolecular Sequence DataFatal OutcomeHepatic VeinsProspective StudiesHeart-Lung TransplantationBase SequenceBiological MarkersTransplantation, AutologousPhenobarbitalMice, KnockoutPostoperative PeriodBrain Tissue TransplantationOrgan SpecificityAntiviral AgentsSpleenPrognosisTransplantation, Heterotopic